We are live on ! Find out more
NDRA icon

ENDRA Life Sciences

5 hedge funds and large institutions have $278K invested in ENDRA Life Sciences in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

78% more capital invested

Capital invested by funds: $156K → $278K (+$122K)

0% more funds holding

Funds holding: 55 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NDRA Hedge Fund Activity: Q4 2023 in Review

5 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2023, worth a combined $278K — up 78% from $156K a quarter earlier.

Fund positioning in NDRA was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $4.21K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $11K sold.

  • 5 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $278K of ENDRA Life Sciences stock for Q4 2023, up 78% quarter-over-quarter.
  • 1 fund opened new ENDRA Life Sciences positions in Q4 2023 and 1 closed out, a net change of 0 holders.
  • The largest ENDRA Life Sciences buyer in Q4 2023 was Geode Capital Management, an estimated $4.21K added.
  • The largest ENDRA Life Sciences seller in Q4 2023 was Renaissance Technologies, an estimated $11K sold.

Based on aggregated 13F filings for Q4 2023.